Tumor-driven evolution of immunosuppressive networks during malignant progression

R Kim, M Emi, K Tanabe, K Arihiro - Cancer research, 2006 - AACR
Tumors evolve mechanisms to escape immune control by a process called immune editing,
which provides a selective pressure in the tumor microenvironment that could lead to …

Role of mitochondria as the gardens of cell death

R Kim, M Emi, K Tanabe - Cancer chemotherapy and pharmacology, 2006 - Springer
Mitochondria play a crucial role in regulating cell death, which is mediated by outer membrane
permeabilization in response to death triggers such as DNA damage and growth factor …

Current status of the molecular mechanisms of anticancer drug-induced apoptosis: the contribution of molecular-level analysis to cancer chemotherapy

R Kim, K Tanabe, Y Uchida, M Emi, H Inoue… - Cancer chemotherapy …, 2002 - Springer
Apoptosis is an important phenomenon in cytotoxicity induced by anticancer drugs. Here,
we review the current status of the molecular mechanisms of anticancer drug-induced …

Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity

R Kim, M Emi, K Tanabe - Immunology, 2006 - Wiley Online Library
Cancer immunosuppression evolves by constitution of an immunosuppressive network
extending from a primary tumour site to secondary lymphoid organs and peripheral vessels and …

The role of Fas ligand and transforming growth factor β in tumor progression: Molecular mechanisms of immune privilege via Fas‐mediated apoptosis and potential …

R Kim, M Emi, K Tanabe, Y Uchida… - … International Journal of …, 2004 - Wiley Online Library
Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in
natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor …

Caspase-dependent and-independent cell death pathways after DNA damage

R Kim, M Emi, K Tanabe - Oncology reports, 2005 - spandidos-publications.com
Apoptosis is known to be an important phenomenon in exerting antitumor response to cancer
therapy, which is regulated by Bcl-2 family proteins through mitochondrial permeability …

[HTML][HTML] Targeted therapy against Bcl-2-related proteins in breast cancer cells

M Emi, R Kim, K Tanabe, Y Uchida, T Toge - Breast cancer research, 2005 - Springer
Introduction Bcl-2 and Bcl-xL confer resistance to apoptosis, thereby reducing the effectiveness
of chemotherapy. We examined the relationship between the expression of Bcl-2 and Bcl-…

Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses

R Kim, M Emi, K Tanabe - Cancer biology & therapy, 2005 - Taylor & Francis
Apoptotic cells can be eliminated by phagocytosis, which is mediated by antigen-presenting
cells (APCs), such as macrophages and dendritic cells (DCs), through phosphatidylserine (…

Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy

R Kim, M Emi, K Tanabe, T Toge - … International Journal of the …, 2004 - Wiley Online Library
Bcl‐2 protein plays a critical role in inhibiting anticancer drug‐induced apoptosis, which is
mediated by a mitochondria‐dependent pathway that controls the release of cytochrome c …

The role of apoptosis in cancer cell survival and therapeutic outcome

R Kim, M Emi, K Tanabe - Cancer biology & therapy, 2006 - Taylor & Francis
A number of discoveries have clarified the molecular mechanism of apoptosis, thus clarifying
the link between apoptosis and therapeutic outcome. Even though apoptosis is thought to …